Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma

Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma

Background: Patients with platinum-refractory disease who experience early treatment failure of head and neck squamous cell carcinoma (HNSCC) exhibit a dismal prognosis. Metronomic chemotherapy is a promising treatment schedule in clinical practice for HNSCC. Oral metronomic chemotherapy with methot...

Full description

Saved in:
Bibliographic Details
Main Authors: Amira Elwan, Adel Bakry, Mohamed Eesa, Hoda Ismail, Mohamed Alnemr
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2025-01-01
Series:Middle East Journal of Cancer
Subjects:
squamous cell carcinoma of head and neck
refractory
methotrexate
celecoxib
metronomic chemotherapy
Online Access:https://mejc.sums.ac.ir/article_50154_c6c8ac1e15d4b896a7dcb4b23c0311e1.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items